SHNUF yields 10.00% · JNJ yields 2.13%● Live data
📍 SHNUF pulled ahead of the other in Year 1
Combined, SHNUF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SHNUF + JNJ for your $10,000?
Intouch Holdings Public Company Limited, through its subsidiaries, engages in the satellite, Internet, telecommunications, and media and advertising businesses. It operates through Local Wireless Telecommunications, Satellite and International Businesses, and Other Businesses segments. The company offers transponder rental and related services for domestic and international communications; broadband content services; satellite uplink-downlink, broadcasting television and telecommunication services; Internet data center, Internet, and telecommunication services; advertising, insurance broker, and other related services; and sale and service related to media, telephone network, mobile content, and engineering development services on communication technology and electronics. It also sells user terminals of IPSTAR and direct television equipment; and distributes internet equipment. In addition, the company offers local mobile telecommunication services; provides computer program and related services, as well as information technology and home shopping services; and trades in and rents telecommunications equipment and accessories. It has operations in Thailand, Australia, India, Japan, Myanmar, Malaysia, and internationally. The company was formerly known as Shin Corporation Public Company Limited and changed its name to Intouch Holdings Public Company Limited in March 2014. Intouch Holdings Public Company Limited was founded in 1983 and is based in Bangkok, Thailand. As of December 31, 2021, Intouch Holdings Public Company Limited operates as a subsidiary of Gulf Energy Development Public Company Limited.
Full SHNUF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.